Fifteen Approved Active Pharmaceutical Ingredients Added To Pharmaceutical Substances Version 3.2

Main Category: Pharmacy / Pharmacist
Article Date: 01 Jun 2009 - 4:00 PDT

email to a friend   printer friendly   view / write opinions   rate article

Thieme Publishing Group is pleased to announce the launch of Pharmaceutical Substances Version 3.2. Available via Thieme-connect, Pharmaceutical Substances is a comprehensive reference guide to every significant pharmaceutical compound and includes all FDA approved active pharmaceutical ingredients (APIs).

Fifteen drugs have been added to the upgraded version of the information resource, bringing the total of APIs to 2,475. Recent additions include Novartis' new anti Malaria drug Riamet, the Japan-only available anti-psychotic drug, Lonasen from Sumitomo Pharma and Evoltra, Bioenvision's new Leukemia treatment. And the monograph for Dexrazoxane has been updated with new synthetic routes.

"We strive to keep Pharmaceutical Substances as current as possible. With this update, important drugs that were approved in the last two years, but not yet covered in the product, have been added," says Dr. Thomas Krimmer, who is in charge of Pharmaceutical Substances at Thieme. "The update is available from mid-May for the users of Thieme's structure- and full text searchable stand-alone electronic version and from the end of this month for the users of the STN version."

Compiled by leaders in the field of pharmaceutical chemistry, in association with InfoChem and FIZ Chemie, the online version of the information resource is an easy-to-navigate, web-based portal that utilizes standard browser technology. The user-friendly interface enables users to rapidly locate data and graphically search structures.

Source
Thieme